Yesterday, the United States House of Representatives officially designated the week of July 14–18, 2025, as "Crypto Week." During this period, lawmakers are set to debate and vote on three major bills: the CLARITY Act, the Anti-CBDC Surveillance State Act, and the Senate-originated GENIUS Act. Backed by House Speaker Mike Johnson, committee chairs French Hill and GT Thompson, and the Trump administration, the initiative is portrayed as an unprecedented effort to solidify the U.S. as the global leader in digital asset innovation.
The proposed legislation outlines clear regulatory frameworks. The CLARITY Act would establish a comprehensive market structure, clarifying which digital assets are securities versus commodities and defining operational standards for exchanges. The Anti-CBDC Act would prohibit the Federal Reserve from issuing a centrally controlled digital dollar, citing privacy concerns. Meanwhile, the GENIUS Act focuses on payment stablecoins, requiring full 1:1 asset backing, robust capital and transparency standards, and federal oversight — effectively transforming them into legally recognized, fully collateralized digital dollars.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appFor the entire crypto ecosystem, these measures promise long-awaited regulatory clarity, potentially keeping startups, capital, and talent within the U.S. while accelerating the tokenization of traditional assets. The U.S. Treasury projects that the stablecoin market could reach $3.7 trillion by 2030 (up from ~$250 billion today), and supporters believe that clear rules will enable this growth. However, skeptics — including Europe’s largest asset manager Amundi — warn that the GENIUS Act could weaken the dollar’s dominance and turn private issuers into “quasi-banks,” threatening global financial stability. Regardless of the outcome, “Crypto Week” is shaping up to be a pivotal moment for U.S. financial policy and the future of digital assets worldwide.
Bitcoin is down slightly today by 0.65%, trading at $108,940, but it remains near its all-time highs.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
